Report: An Activist’s Guide to Tuberculosis Drugs
In the guide, TAG argues that TB treatment must be shorter, simpler, less toxic and more tolerable and affordable.
The think tank has published the guide in the hopes that activists can contribute to the development and uptake of improved TB treatment by calling attention to research, quality of medications, and access priorities.
The guide provides a brief summary of safety and efficacy data for those drugs currently in use for TB, many of which have been approved for other diseases but are used off-label for TB. It highlights enrolling paediatric trials for the TB drug delamanid in South Africa as well as the country’s use of terizidone as a last report drug for drug-resistant TB.
As of March 2014, delamanid had not yet been registered for use in South Africa.
Download the guide: An Activist’s Guide to Tuberculosis Drugs
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Report: An Activist’s Guide to Tuberculosis Drugs
by healthe, Health-e News
June 5, 2014